Gene · 54567
Papers4,267
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 4,267
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hsa_circ_0005623 is an indicator for pulmonary artery hypertension associated with congenital heart disease. | Front Cardiovasc Med | 2025 | 41602344 | PubTator, text mining | PubMed |
| Adams-Oliver Syndrome: A Clinical Diagnosis in the Genomic Era. | Cureus | 2025 | 41552262 | PubTator, text mining | PubMed |
| Adams-Oliver Syndrome: A Comprehensive Literature Review of Clinical, Nutritional, Genetic, and Molecular Aspects with Nursing Care Considerations. | Int J Mol Sci | 2025 | 41516051 | PubTator, text mining | PubMed |
| DLL4+ neutrophils promote Notch1-mediated endothelial PANoptosis to exacerbate acute lung injury in sepsis. | J Clin Invest | 2025 | 41392977 | PubTator, text mining | PubMed |
Mechanistic study of HIF-1α-mediated regulation of the Notch1 pathway in promoting radioresistance in head and neck squamous cell carcinoma: a comprehensive analysis based on bioinformatics and functional experiments. | BMC Cancer | 2025 | 41388392 | PubTator, text mining | PubMed |
| Unraveling hematopoietic stem cell ontogeny through single-cell multi-omics approaches. | Front Cell Dev Biol | 2025 | 41358001 | PubTator, text mining | PubMed |
| Disruption of Notch signaling by KGF induces a developmental pause in thymocytes. | Front Immunol | 2025 | 41357235 | PubTator, text mining | PubMed |
| Delta-like ligand 4 mediated myeloid-derived suppressor cell metabolic reprogramming promotes neoadjuvant therapy resistance in titin-inactivated triple-negative breast cancer. | Mol Biomed | 2025 | 41326912 | PubTator, text mining | PubMed |
| Ardisiaoside A, a new triterpenoid glycoside from Ardisia gigantifolia, induces cell senescence and targets cancer stem cells in gastric cancer. | Biomed Pharmacother | 2025 | 41319517 | PubTator, text mining | PubMed |
| Targeting Endothelial PERK Accelerates Lymphoid Regeneration by Enhancing DLL4-NOTCH3 Signaling at the Pre-B Niche. | bioRxiv | 2025 | 41279257 | PubTator, text mining | PubMed |
| Placental Malperfusion Is Associated With Adverse Outcomes in Congenital Heart Disease and With Genetic Variants in Placental Developmental Pathways. | J Am Coll Cardiol | 2025 | 41193091 | PubTator, text mining | PubMed |
| Neuralized-like proteins differentially activate Notch ligands. | EMBO Rep | 2025 | 41174261 | PubTator, text mining | PubMed |
| Optimizing dosimetric leaf gap parameters for radiation therapy: A comparative study using three diode-array verification tools and an ionization chamber. | J Appl Clin Med Phys | 2025 | 41147406 | PubTator, text mining | PubMed |
| Differential O-glucose elongation on a specific EGF repeat within the canonical ligand-binding domain regulates DLL1/4-NOTCH1 signaling. | Proc Natl Acad Sci U S A | 2025 | 41129232 | PubTator, text mining | PubMed |
| A post-implantation model of human embryo development includes a definitive hematopoietic niche. | Cell Rep | 2025 | 41086808 | PubTator, text mining | PubMed |
| Role of the Notch ligand DLL4 in the immune response of children with Mycoplasma pneumoniae pneumonia. | Rev Inst Med Trop Sao Paulo | 2025 | 41059856 | PubTator, text mining | PubMed |
| Novel De Novo DLL4 Missense and Highly Accurate Protein Structure Prediction in Adams-Oliver Type 6 Syndrome. | Clin Case Rep | 2025 | 41040836 | PubTator, text mining | PubMed |
| Crosstalk between endothelial cells and osteoblasts stimulates ALP via Notch signaling and RANKL/OPG ratio independently of Notch signaling in vitro. | Cell Mol Biol Lett | 2025 | 41039204 | PubTator, text mining | PubMed |
| An integrated 2D framework for quantifying cellular mechanics reveals the impact of juxtacrine Notch signalling on directed collective migration of endothelial cells. | BMC Biol | 2025 | 41034913 | PubTator, text mining | PubMed |
| Tethered Antigenic Suppression Shields the Hemagglutinin Head Domain and Refocuses the Antibody Response to the Stalk Domain. | Chemistry (Basel) | 2025 | 41017907 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54567/papers?page=5